Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Greggs PLC Board/Management Information 2026

Jun 8, 2026

4679_rns_2026-06-08_ef5f229f-6bcc-4d01-bd4d-22fe6f5d08c0.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2654H

Greggs PLC

08 June 2026

8 June 2026

Greggs PLC

Appointment of Non-Executive Director

The Board of Greggs plc is pleased to announce the appointment of Ikdeep Singh as an independent Non-Executive Director, effective from 1 July 2026.

Ikdeep is currently Global President of Mars Pet Nutrition, a division within the company's $30 billion Petcare business with operations in more than 120 markets. Before joining Mars, he served as President of L'Oréal's North American business and held senior roles at Procter & Gamble across North America, Greater China and global markets. He holds an MBA from the Wharton School at the University of Pennsylvania.

Ikdeep brings extensive experience of leading large consumer businesses across operations, supply chain, innovation and digital transformation. His expertise in business transformation and digital modernisation will support Greggs as it continues to deliver its growth strategy

Matt Davies, Chair of Greggs, said: "We are delighted to welcome Ikdeep to the Board. He brings significant leadership experience in global consumer businesses, together with strong operational and digital expertise. We look forward to the new perspectives he will bring to the Board."

There is no further information to be disclosed pursuant to UKLR 6.4.8R in relation to Ikdeep Singh.

ENDS

ENQUIRIES:

Greggs PLC

Roisin Currie, Chief Executive

Richard Hutton, Chief Financial Officer

David Watson, Head of IR
Hudson Sandler

Wendy Baker / Emily Brooker
Tel: 0191 281 7721 Email: [email protected]

Tel: 020 7796 4133

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAMZGGVKKZGVZM